UFP Technologies reports record Q1: revenue $148.1M (+41%), net income $17.2M (+35%), EPS $2.21

UFP TECHNOLOGIES INC

2025-Q1 EPS reported $2.21 revenue$148,148,000

Net sales $148.1M vs $105.0M (+41.1%); MedTech sales up 50.4% to $135.4M.
GAAP diluted EPS $2.21 vs $1.64; adjusted EPS $2.47 vs $1.77; adjusted EBITDA $30.2M (+45.9%).
MedTech organic growth 5.4% despite 6% Robotic Surgery decline; overall organic growth 2.3%.
Exclusive manufacturing agreement with second-largest customer for Safe Patient Handling through June 2030; Dominican Republic expansion.
Closed small fold-in acquisition (former sister company of AJR); balance sheet strengthened with debt paydown.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.